FDA investigates death of boy who got Elevidys, Roche says death unrelated to therapy

The FDA said Friday night that it is probing the June 7 death of an 8-year-old boy who received Elevidys, the Duchenne muscular gene therapy from Sarepta Therapeutics. A Sarepta spokesperson ...